Filed: 5/5/2026ACC: 0001766721-26-000002
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $476.29M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$476.29M
Total AUM (reported)
14.39M
Total Shares
Allocation by class
COM$458.47M96.3%
COM NEW$9.53M2.0%
SPONSORED ADS$7.92M1.7%
COM CL A$366.8K0.1%
Portfolio Concentration
Top 3$434.31M91.2%
4–10$39.56M8.3%
11–25$2.42M0.5%
Top 3 weight
91.2%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 14.39M
Sole
Full voting authority
14.39M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares5.09M
TypeSH
Market value$377.95M
79.35%
Sole
5.09M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.32M
TypeSH
Market value$30.76M
6.46%
Sole
1.32M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.56M
TypeSH
Market value$25.59M
5.37%
Sole
1.56M
Shared
0.00
None
0.00
Bicara Therapeutics Inc. (BCAX)
SOLEShares568.92K
TypeSH
Market value$11.32M
2.38%
Sole
568.92K
Shared
0.00
None
0.00
BridgeBio Oncology Therapeutics (BBOT)
SOLEShares1.02M
TypeSH
Market value$9.11M
1.91%
Sole
1.02M
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares1.43M
TypeSH
Market value$7.92M
1.66%
Sole
1.43M
Shared
0.00
None
0.00
Scholar Rock Holding Corporation (SRRK)
SOLEShares77.03K
TypeSH
Market value$3.79M
0.80%
Sole
77.03K
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares2.05M
TypeSH
Market value$3.13M
0.66%
Sole
2.05M
Shared
0.00
None
0.00
Eupraxia Pharmaceuticals Inc. (EPRX)
SOLEShares325K
TypeSH
Market value$2.35M
0.49%
Sole
325K
Shared
0.00
None
0.00
Urogen Pharma Ltd. (URGN)
SOLEShares108K
TypeSH
Market value$1.94M
0.41%
Sole
108K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$1.63M
0.34%
Sole
434.45K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares325.37K
TypeSH
Market value$423.0K
0.09%
Sole
325.37K
Shared
0.00
None
0.00
OnKure Therapeutics, Inc. (OKUR)
SOLEShares88.61K
TypeSH
Market value$366.8K
0.08%
Sole
88.61K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 5.09M | SH | $377.95M 79.35% | 5.09M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.32M | SH | $30.76M 6.46% | 1.32M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.56M | SH | $25.59M 5.37% | 1.56M | 0.00 | 0.00 |
Bicara Therapeutics Inc. (BCAX)SOLE | COM | 568.92K | SH | $11.32M 2.38% | 568.92K | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics (BBOT)SOLE | COM NEW | 1.02M | SH | $9.11M 1.91% | 1.02M | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 1.43M | SH | $7.92M 1.66% | 1.43M | 0.00 | 0.00 |
Scholar Rock Holding Corporation (SRRK)SOLE | COM | 77.03K | SH | $3.79M 0.80% | 77.03K | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 2.05M | SH | $3.13M 0.66% | 2.05M | 0.00 | 0.00 |
Eupraxia Pharmaceuticals Inc. (EPRX)SOLE | COM | 325K | SH | $2.35M 0.49% | 325K | 0.00 | 0.00 |
Urogen Pharma Ltd. (URGN)SOLE | COM | 108K | SH | $1.94M 0.41% | 108K | 0.00 | 0.00 |
Aclaris Therapeutics Inc (ACRS)SOLE | COM | 434.45K | SH | $1.63M 0.34% | 434.45K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM NEW | 325.37K | SH | $423.0K 0.09% | 325.37K | 0.00 | 0.00 |
OnKure Therapeutics, Inc. (OKUR)SOLE | COM CL A | 88.61K | SH | $366.8K 0.08% | 88.61K | 0.00 | 0.00 |